Insulet (PODD) Convertible Debt (2010 - 2011)

Insulet (PODD) posted Convertible Debt of $106.3 million for Q3 2011, up 2.06% on a QoQ basis from $104.2 million in Q2 2011.

Insulet (PODD) Convertible Debt (2010 - 2011) Analysis & Trends

Insulet's Convertible Debt history runs 2 years deep, the most recent figure standing at $106.3 million for Q3 2011.

Quarterly Convertible Debt changed N/A year-over-year to $106.3 million in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $106.3 million (changed N/A YoY) and the FY2010 annual result came in at $69.4 million, changed N/A from the prior year.
Convertible Debt was $106.3 million for Q3 2011 at Insulet, up from $104.2 million in the prior quarter.
Across five years, Convertible Debt topped out at $106.3 million in Q3 2011 and bottomed at $69.4 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn
10	Insulet	11.52 Bn	11.04 Bn	529.10 Mn

Download Data